Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 21 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 9771358

    Dihydropyrimidine compounds and their application in pharmaceuticals

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  2. US 9770456

    Compositions comprising acidic extracts of mastic gum

    REGENERA PHARMA LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  3. US 9770469

    Methods of reprogramming renal cells

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  4. US 9763993

    Process for manufacturing glatiramer acetate product

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  5. US 9765378

    Preparation method of new recombinant antibacterial polypeptide medicine

    Creative Trio Biotech (Beijing) Co., Ltd. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  6. US 9758831

    Methods of predicting clinical course and treating multiple sclerosis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  7. US 9737477

    Anti-aging dietary composition containing polysaccharides derived from ginseng and tuber fleeceflower root

    INFINITUS (CHINA) COMPANY LTD. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  8. US 9737571

    Compositions of aquatic origin for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  9. US 9738629

    Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  10. US 9732333

    Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells

    Protalix Ltd. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  11. US 9732124

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  12. US 9724367

    Injectable formulations for organ augmentation

    RegenMed (Cayman) LTD. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  13. US 9724345

    Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same

    Platform Brightworks Two, Ltd. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  14. US 9724374

    Capsule containing total flavonoids of desmodium styracifolium, method for preparing the same and use

    WUHAN CHEMLIGAND BIO-PHARMACEUTICAL CO., LTD. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  15. US 9718841

    Bicyclic pyrazolone compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted
  16. US 9714232

    Substituted piperazine compounds and methods of use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted
  17. US 9707262

    Composition with anoxia-tolerant and anti-fatigue effects and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  18. US 9708595

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  19. US 9709703

    Ophthalmic lens material, ophthalmic lens, and method for making the same

    HON HAI PRECISION INDUSTRY CO., LTD. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  20. US 9702007

    Genetic markers predictive of response to glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  21. US 9700600

    Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same

    REGENTIS BIOMATERIALS LTD. · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  22. US 9695150

    Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted
  23. US 9687522

    Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted
  24. US 9688697

    RNA polymerase I inhibitors and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted